Illumina Inc. stock underperforms Friday when compared to competitors
Shares of Illumina Inc. ILMN shed 1.51% to $100.24 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...
Icahn boosts CVR Partners, cuts Illumina in Q4
Carl Icahn’s Icahn Capital disclosed in an SEC filing its holdings as of December 31, 2024. The fund increased its stakes in two holdings, ...
Hosted on MSN1d
How Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff war
China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Jim Cramer on China’s Crackdown on Illumina (ILMN): “There Are Two Other Companies That Do What They Do”
We recently published a list of Jim Cramer Discusses These 10 Stocks & Dissects President Trump’s China Tariffs. In this ...
Genomic Data Analysis and Interpretation Market Research 2025-2033: Syngenta Group Leads, Followed by Amgen, Monsanto (Bayer), and Illumina
The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...
Illumina Inc. stock underperforms Monday when compared to competitors
Shares of Illumina Inc. ILMN shed 5.47% to $104.99 Monday, on what proved to be an all-around favorable trading session for ...
Fintel on MSN5d
Barclays Downgrades Illumina (ILMN)
Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to Underweight. Analyst Price Forecast Suggests 49.02% Upside As of January ...
Morgan Stanley Remains a Hold on Illumina (ILMN)
Morgan Stanley analyst Tejas Savant maintained a Hold rating on Illumina (ILMN – Research Report) today and set a price target of $136.00. The ...